Health Economics of Cardiovascular Disease in the United States

Karen Joynt MaddoxCardiologist, Washington University School of Medicine

“Importantly, much of the projected growth in cardiovascular spending is not driven by rising costs per patient, but by the increasing number of Americans living with CVD and its risk factors.”

“A strategic and comprehensive approach involving expertise across a wide range of fields should be taken to understand factors underlying inequities with respect to CV care and outcomes in minority populations, and to develop innovative programs that counteract the fragmented nature of US healthcare delivery, with a focus on the needs of the elderly.”

“The bottom line is that patients with cardiovascular conditions are paying more and getting no relief, and that's been true for a decade and a half.”